CN105954447B - A method of lactone enantiomter is stood by HPLC Analyze & separate benzoyl section - Google Patents
A method of lactone enantiomter is stood by HPLC Analyze & separate benzoyl section Download PDFInfo
- Publication number
- CN105954447B CN105954447B CN201610574784.8A CN201610574784A CN105954447B CN 105954447 B CN105954447 B CN 105954447B CN 201610574784 A CN201610574784 A CN 201610574784A CN 105954447 B CN105954447 B CN 105954447B
- Authority
- CN
- China
- Prior art keywords
- lactone
- benzoyl section
- enantiomter
- benzoyl
- hexane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000002596 lactones Chemical class 0.000 title claims abstract description 107
- 125000003236 benzoyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C(*)=O 0.000 title claims abstract description 43
- 238000000034 method Methods 0.000 title claims abstract description 24
- 238000004128 high performance liquid chromatography Methods 0.000 title claims abstract description 11
- -1 (±)-benzoyl Chemical group 0.000 claims description 66
- 239000012452 mother liquor Substances 0.000 claims description 30
- 238000012360 testing method Methods 0.000 claims description 28
- 239000007788 liquid Substances 0.000 claims description 18
- 239000012085 test solution Substances 0.000 claims description 18
- 238000001514 detection method Methods 0.000 claims description 16
- 238000002474 experimental method Methods 0.000 claims description 15
- 238000005070 sampling Methods 0.000 claims description 15
- 239000000203 mixture Substances 0.000 claims 3
- 238000000926 separation method Methods 0.000 abstract description 7
- 230000003287 optical effect Effects 0.000 abstract description 6
- 238000004458 analytical method Methods 0.000 abstract description 4
- 239000012046 mixed solvent Substances 0.000 abstract description 4
- 238000002360 preparation method Methods 0.000 abstract description 4
- 229920000856 Amylose Polymers 0.000 abstract description 2
- 239000000523 sample Substances 0.000 description 40
- 229960000935 dehydrated alcohol Drugs 0.000 description 29
- 239000012071 phase Substances 0.000 description 23
- 239000000243 solution Substances 0.000 description 20
- QKGYJVXSKCDGOK-UHFFFAOYSA-N hexane;propan-2-ol Chemical compound CC(C)O.CCCCCC QKGYJVXSKCDGOK-UHFFFAOYSA-N 0.000 description 13
- KFZMGEQAYNKOFK-UHFFFAOYSA-N isopropyl alcohol Natural products CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 12
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 11
- 229940079593 drug Drugs 0.000 description 9
- 239000003814 drug Substances 0.000 description 9
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 8
- 229940127293 prostanoid Drugs 0.000 description 6
- 150000003814 prostanoids Chemical class 0.000 description 6
- 239000012535 impurity Substances 0.000 description 5
- 239000012488 sample solution Substances 0.000 description 5
- 238000006243 chemical reaction Methods 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 238000004587 chromatography analysis Methods 0.000 description 3
- 230000007812 deficiency Effects 0.000 description 3
- 150000002148 esters Chemical group 0.000 description 3
- 150000002240 furans Chemical class 0.000 description 3
- 150000003180 prostaglandins Chemical class 0.000 description 3
- 238000003786 synthesis reaction Methods 0.000 description 3
- 125000001231 benzoyloxy group Chemical group C(C1=CC=CC=C1)(=O)O* 0.000 description 2
- 239000000945 filler Substances 0.000 description 2
- 125000004029 hydroxymethyl group Chemical group [H]OC([H])([H])* 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 229940094443 oxytocics prostaglandins Drugs 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- KXDHJXZQYSOELW-UHFFFAOYSA-M Carbamate Chemical compound NC([O-])=O KXDHJXZQYSOELW-UHFFFAOYSA-M 0.000 description 1
- 230000005526 G1 to G0 transition Effects 0.000 description 1
- OBRRYUZUDKVCOO-FVCCEPFGSA-N [(3ar,4s,5r,6as)-4-(hydroxymethyl)-2-oxo-3,3a,4,5,6,6a-hexahydrocyclopenta[b]furan-5-yl] benzoate Chemical compound O([C@H]1[C@@H]([C@H]2CC(=O)O[C@H]2C1)CO)C(=O)C1=CC=CC=C1 OBRRYUZUDKVCOO-FVCCEPFGSA-N 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 125000001449 isopropyl group Chemical group [H]C([H])([H])C([H])(*)C([H])([H])[H] 0.000 description 1
- 239000007791 liquid phase Substances 0.000 description 1
- SYSQUGFVNFXIIT-UHFFFAOYSA-N n-[4-(1,3-benzoxazol-2-yl)phenyl]-4-nitrobenzenesulfonamide Chemical class C1=CC([N+](=O)[O-])=CC=C1S(=O)(=O)NC1=CC=C(C=2OC3=CC=CC=C3N=2)C=C1 SYSQUGFVNFXIIT-UHFFFAOYSA-N 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 239000007858 starting material Substances 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/60—Construction of the column
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N30/04—Preparation or injection of sample to be analysed
- G01N30/06—Preparation
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N30/00—Investigating or analysing materials by separation into components using adsorption, absorption or similar phenomena or using ion-exchange, e.g. chromatography or field flow fractionation
- G01N30/02—Column chromatography
- G01N2030/022—Column chromatography characterised by the kind of separation mechanism
- G01N2030/027—Liquid chromatography
Landscapes
- Physics & Mathematics (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Immunology (AREA)
- Pathology (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
Description
Claims (1)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610574784.8A CN105954447B (en) | 2016-07-21 | 2016-07-21 | A method of lactone enantiomter is stood by HPLC Analyze & separate benzoyl section |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610574784.8A CN105954447B (en) | 2016-07-21 | 2016-07-21 | A method of lactone enantiomter is stood by HPLC Analyze & separate benzoyl section |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105954447A CN105954447A (en) | 2016-09-21 |
CN105954447B true CN105954447B (en) | 2018-12-28 |
Family
ID=56901146
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610574784.8A Active CN105954447B (en) | 2016-07-21 | 2016-07-21 | A method of lactone enantiomter is stood by HPLC Analyze & separate benzoyl section |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105954447B (en) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107064336B (en) * | 2017-02-28 | 2023-06-06 | 长春百纯和成医药科技有限公司 | Method for separating enantiomer of Colalactone diol by pre-column derivatization analysis |
CN107085058A (en) * | 2017-05-12 | 2017-08-22 | 成都丽凯手性技术有限公司 | A kind of PHBA enantiomters method for detecting impurities |
CN108956808B (en) * | 2018-06-04 | 2021-07-20 | 吉林医药学院 | A kind of HPLC method analysis and preparation method of diacetylcorilactone enantiomer |
CN108693272B (en) * | 2018-06-04 | 2021-03-12 | 吉林百纯化学科技有限公司 | Method for analyzing and preparing N- (p-toluenesulfonyl) -L-alanine and enantiomer thereof by HPLC method |
CN112229923B (en) * | 2020-09-30 | 2022-11-11 | 东北制药集团股份有限公司 | Method for detecting 15-ketone and related substances thereof by adopting high performance liquid chromatography |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0501310A1 (en) * | 1991-02-27 | 1992-09-02 | Nissan Chemical Industries Ltd. | Method for optical resolution of corey lactone diols |
US20020095061A1 (en) * | 1996-10-08 | 2002-07-18 | Dsm Catalytica Pharmaceuticals, Inc. | Preparation of chiral 6,7-dihydroxy geranyloxy compounds |
WO2007066160A1 (en) * | 2005-12-09 | 2007-06-14 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Process for the separation of optical isomers of the corey lactone |
CN103604895A (en) * | 2013-12-05 | 2014-02-26 | 武汉武药科技有限公司 | Method for analytical separation of (-) benzoyl Corey lactone optical isomers by HPLC |
CN105784878A (en) * | 2016-05-13 | 2016-07-20 | 长春百纯和成医药科技有限公司 | Method for analyzing and separating cis-bicyclo[3,2,0]hept-2-ene-6-one enantiomer by HPLC (High Performance Liquid Chromatography) |
-
2016
- 2016-07-21 CN CN201610574784.8A patent/CN105954447B/en active Active
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0501310A1 (en) * | 1991-02-27 | 1992-09-02 | Nissan Chemical Industries Ltd. | Method for optical resolution of corey lactone diols |
US20020095061A1 (en) * | 1996-10-08 | 2002-07-18 | Dsm Catalytica Pharmaceuticals, Inc. | Preparation of chiral 6,7-dihydroxy geranyloxy compounds |
WO2007066160A1 (en) * | 2005-12-09 | 2007-06-14 | CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. | Process for the separation of optical isomers of the corey lactone |
CN103604895A (en) * | 2013-12-05 | 2014-02-26 | 武汉武药科技有限公司 | Method for analytical separation of (-) benzoyl Corey lactone optical isomers by HPLC |
CN105784878A (en) * | 2016-05-13 | 2016-07-20 | 长春百纯和成医药科技有限公司 | Method for analyzing and separating cis-bicyclo[3,2,0]hept-2-ene-6-one enantiomer by HPLC (High Performance Liquid Chromatography) |
Also Published As
Publication number | Publication date |
---|---|
CN105954447A (en) | 2016-09-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105954447B (en) | A method of lactone enantiomter is stood by HPLC Analyze & separate benzoyl section | |
Wolf | Dynamic stereochemistry of chiral compounds: principles and applications | |
US9987320B2 (en) | Traditional chinese medicine composition, and preparation and application thereof | |
JP6906307B2 (en) | Chinese herbal medicine compositions, their formulations and uses | |
WO2014198123A1 (en) | R type resveratrol dimer, preparation method therefor and use thereof in reducing blood sugar | |
CN105784878B (en) | A kind of method of the cis bicyclic ketone enantiomter of 2 alkene in [3,2,0] heptan 6 of HPLC methods Analyze & separate | |
Zhang et al. | Separation of amlodipine besilate enantiomers by biphasic recognition recycling high-speed counter-current chromatography | |
CN102083790A (en) | Spiro(5.5)undecane derivatives | |
CN103604895B (en) | Method for analytical separation of (-) benzoyl Corey lactone optical isomers by HPLC | |
CN106198808B (en) | A kind of method that HPLC Analyze & separates found lactone enantiomter to phenyl benzoyl section | |
CN108693272A (en) | A kind of analysis of HPLC methods and prepare N-(P-toluenesulfonyl)The method of l-Alanine and its enantiomter | |
CN107064336A (en) | A kind of method of pre-column derivatization Analyze & separate Ke Linei esterdiol enantiomters | |
RU2727890C1 (en) | Method for preparative separation of racemic salbutamol base using supercritical fluid chromatography | |
CN102464586B (en) | Preparation method of danshinolic acid A | |
CN102207494B (en) | Method for simultaneously determining four optical isomers of palonosetron hydrochloride | |
WO2020107629A1 (en) | Use of high-speed countercurrent chromatograph in bioconversion of glycoside component | |
CN104502470B (en) | A method for separating R/S-3-quinuclidinol by pre-column derivatization high performance liquid chromatography | |
CN108061773B (en) | The method of high-efficient liquid phase chromatogram technology measurement vitamin A | |
CN101881755B (en) | Method for detecting esmolol hydrochlorid optical isomer by high efficiency liquid chromatography | |
CN109115934A (en) | The high pressure liquid phase quantitative detecting method and its application of 18 α-and 18 β-epimer in enoxolone stearyl | |
CN105467031A (en) | Chromatographic method for measuring content of vitamin E by HPLC | |
TWI415842B (en) | New process | |
JP2004532246A (en) | Substituted C-furan-2-yl-methylamine- and C-thiophen-2-yl-methylamine-derivatives | |
CN103207247A (en) | Method of separating and determining aliskiren intermediate and optical isomers thereof by using liquid chromatography | |
CN107505410A (en) | The method that high performance liquid chromatography splits Nateglinide and its stereoisomer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB03 | Change of inventor or designer information |
Inventor after: Xiu Zhiming Inventor after: Wang Shuhong Inventor after: Li Li Inventor after: Zhao Chunying Inventor after: Peng Yue Inventor after: Li Yujia Inventor before: Wang Shuhong Inventor before: Li Li Inventor before: Peng Yue Inventor before: Li Yujia Inventor before: Li Zhibo Inventor before: Xiu Zhiming |
|
CB03 | Change of inventor or designer information | ||
TA01 | Transfer of patent application right |
Effective date of registration: 20181025 Address after: 132021 25 Zunyi East Road, Longtan District, Jilin, Jilin Applicant after: Jilin 100 Pure Chemical Technology Co., Ltd. Address before: 130000 668 innovation road, hi tech Zone, Changchun, Jilin Applicant before: CHANGCHUN BC&HC PHARMACEUTICAL TECHNOLOGY CO., LTD. |
|
TA01 | Transfer of patent application right | ||
GR01 | Patent grant | ||
GR01 | Patent grant |